Tel Hashomer camptodactyly syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3292OMIM:211960Q74.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Tel Hashomer camptodactyly syndrome is an extremely rare genetic disorder characterized by the combination of camptodactyly (permanent flexion contractures of the fingers), muscular hypoplasia (underdevelopment of muscles), and skeletal abnormalities. The condition was first described in patients from the Tel Hashomer Medical Center in Israel. Key clinical features include camptodactyly affecting multiple fingers, muscle wasting and weakness, short stature, and distinctive facial features. Affected individuals may also present with spinal abnormalities such as scoliosis or kyphosis, joint limitations, and connective tissue involvement. The musculoskeletal system is primarily affected, with patients often showing generalized muscle hypoplasia and reduced muscle bulk, particularly in the limbs. The syndrome may also be associated with mitral valve prolapse and other connective tissue manifestations, suggesting a broader involvement beyond the musculoskeletal system. Intelligence is typically normal in affected individuals. The condition is present from birth, with camptodactyly and muscular findings being apparent in the neonatal or early infantile period. Diagnosis is based on clinical findings, as no specific genetic locus has been definitively identified. There is no cure for Tel Hashomer camptodactyly syndrome, and management is supportive, focusing on physical therapy to maximize joint mobility, orthopedic interventions for skeletal deformities, and monitoring for cardiac involvement. Surgical correction of finger contractures may be considered in some cases but outcomes vary.

Also known as:

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Tel Hashomer camptodactyly syndrome.

View clinical trials →

No actively recruiting trials found for Tel Hashomer camptodactyly syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Tel Hashomer camptodactyly syndrome community →

No specialists are currently listed for Tel Hashomer camptodactyly syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Tel Hashomer camptodactyly syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Tel Hashomer camptodactyly syndromeForum →

No community posts yet. Be the first to share your experience with Tel Hashomer camptodactyly syndrome.

Start the conversation →

Latest news about Tel Hashomer camptodactyly syndrome

No recent news articles for Tel Hashomer camptodactyly syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Tel Hashomer camptodactyly syndrome

What is Tel Hashomer camptodactyly syndrome?

Tel Hashomer camptodactyly syndrome is an extremely rare genetic disorder characterized by the combination of camptodactyly (permanent flexion contractures of the fingers), muscular hypoplasia (underdevelopment of muscles), and skeletal abnormalities. The condition was first described in patients from the Tel Hashomer Medical Center in Israel. Key clinical features include camptodactyly affecting multiple fingers, muscle wasting and weakness, short stature, and distinctive facial features. Affected individuals may also present with spinal abnormalities such as scoliosis or kyphosis, joint limi

How is Tel Hashomer camptodactyly syndrome inherited?

Tel Hashomer camptodactyly syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Tel Hashomer camptodactyly syndrome typically begin?

Typical onset of Tel Hashomer camptodactyly syndrome is neonatal. Age of onset can vary across affected individuals.